Jefferies Financial Group’s Immunome IMNM Stock Holding History

Jefferies Financial Group’s Portfolio IMNM Stock Details IMNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$25.4M	Sell	1,160,715 -839,285	-42%	-$18.7M	0.17%	95
2025 Q4	$43M	Sell	2,000,000 -100,000	-5%	-$1.76M	0.22%	86
2025 Q3	$24.6M	Buy	2,100,000 +14,340	+0.7%	+$143K	0.12%	128
2025 Q2	$19.4M	Sell	2,085,660 -202,340	-9%	-$1.66M	0.16%	104
2025 Q1	$15.4M	Buy	2,288,000 +288,000	+14%	+$2.76M	0.14%	98
2024 Q4	$21.2M	Buy	2,000,000 +124,108	+7%	+$1.5M	0.13%	121
2024 Q3	$27.4M	Buy	+1,875,892	New	+$26.7M	0.2%	66
2024 Q2	–	Sell	-8,740	Closed	-$216K	–	1615
2024 Q1	$216K	Buy	+8,740	New	+$177K	﹤0.01%	1318

Other funds holding IMNM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Jefferies Financial Group's IMNM Position: Q1 2026 in Review

Jefferies Financial Group reduced its Immunome (IMNM) stake by 42% in Q1 2026, selling an estimated $18.7M and leaving 1,160,715 shares worth $25.4M. The position accounts for 0.17% of the portfolio, ranked #95.

Jefferies Financial Group first reported a position in IMNM in Q1 2024 and has held it in 8 quarters since. The position peaked at $43M in Q4 2025. 201 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

Jefferies Financial Group held 1,160,715 shares of Immunome worth $25.4M as of Q1 2026.
Jefferies Financial Group sold 839,285 Immunome shares in Q1 2026, an estimated $18.7M.
Immunome made up 0.17% of Jefferies Financial Group's portfolio in Q1 2026, its #95 holding.
Jefferies Financial Group first reported a position in Immunome in Q1 2024 and has held it in 8 quarters since.
Jefferies Financial Group's Immunome position peaked at $43M in Q4 2025.
201 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.